These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29481859)

  • 41. Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.
    Li J; Patel D; Wang G
    AAPS J; 2017 Mar; 19(2):321-333. PubMed ID: 27896684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients.
    Vogt M; Kunath K; Dressman JB
    Eur J Pharm Biopharm; 2008 Feb; 68(2):330-7. PubMed ID: 17574401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative Analysis of Drug Supersaturation Region by Temperature-Variable Nuclear Magnetic Resonance Measurements, Part 1: Effects of Polymer and Drug Chiralities.
    Ueda K; Higashi K; Moribe K
    Mol Pharm; 2023 Apr; 20(4):1861-1871. PubMed ID: 36939575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D; Chauhan H; Atef E
    J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Pharm Res; 2016 May; 33(5):1276-88. PubMed ID: 26892947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Drug-Polymer Interaction in Amorphous Solid Dispersion Aiming for the Supersaturation of Poorly Soluble Drug in Biorelevant Medium.
    Mendes C; Andrzejewski RG; Pinto JMO; de Novais LMR; Barison A; Silva MAS; Parize AL
    AAPS PharmSciTech; 2020 Jul; 21(5):189. PubMed ID: 32651739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
    Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Numerical simulation of hot-melt extrusion processes for amorphous solid dispersions using model-based melt viscosity.
    Bochmann ES; Steffens KE; Gryczke A; Wagner KG
    Eur J Pharm Biopharm; 2018 Mar; 124():34-42. PubMed ID: 29221654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
    Al-Obaidi H; Lawrence MJ; Buckton G
    J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Micro-scale prediction method for API-solubility in polymeric matrices and process model for forming amorphous solid dispersion by hot-melt extrusion.
    Bochmann ES; Neumann D; Gryczke A; Wagner KG
    Eur J Pharm Biopharm; 2016 Oct; 107():40-8. PubMed ID: 27349807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strategies for improving the payload of small molecular drugs in polymeric micelles.
    Zhang Y; Ren T; Gou J; Zhang L; Tao X; Tian B; Tian P; Yu D; Song J; Liu X; Chao Y; Xiao W; Tang X
    J Control Release; 2017 Sep; 261():352-366. PubMed ID: 28163211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrated Janus nanofibers enabled by a co-shell solvent for enhancing icariin delivery efficiency.
    Sun Y; Zhou J; Zhang Z; Yu DG; Bligh SWA
    Int J Pharm; 2024 Jun; 658():124180. PubMed ID: 38705246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual-mechanism gastroretentive drug delivery system loaded with an amorphous solid dispersion prepared by hot-melt extrusion.
    Vo AQ; Feng X; Pimparade M; Ye X; Kim DW; Martin ST; Repka MA
    Eur J Pharm Sci; 2017 May; 102():71-84. PubMed ID: 28257881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of copolymer composition on the phase behavior of solid dispersions.
    Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
    Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of two DSC-based methods to predict drug-polymer solubility.
    Rask MB; Knopp MM; Olesen NE; Holm R; Rades T
    Int J Pharm; 2018 Apr; 540(1-2):98-105. PubMed ID: 29425764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Encapsulation of poorly water-soluble drugs into organic nanotubes for improving drug dissolution.
    Moribe K; Makishima T; Higashi K; Liu N; Limwikrant W; Ding W; Masuda M; Shimizu T; Yamamoto K
    Int J Pharm; 2014 Jul; 469(1):190-6. PubMed ID: 24746412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.